CTI Clinical Trial and Consulting Services (CTI) announces the formation of a new United Kingdom affiliate, CTI Clinical Trial and Consulting Services UK Ltd., and the opening of an office outside of London, England.
“The new company and UK location allows CTI to continue to better serve the growing base of global pharmaceutical and biotechnology companies throughout Western Europe,” states Patrick Earley, General Manager at CTI. “Additionally, the UK pharmaceutical and biotechnology industry is extremely important to medical research as a whole, and UK medical centers perform a great deal of research in the critically ill patient population that CTI excels at, so this is a great opportunity.”
CTI has been working for more than a decade in the drug development industry in North America, Europe, and South America, specializing in clinical research programs involving critically ill patient populations.
About CTI Clinical Trial and Consulting Services
CTI is a specialty drug and market development company offering a full range of services that encompass the entire lifecycle of drug development. These services include regulatory pathway design, clinical trial management, data analysis, medical writing, CME and training program development, market analysis and development and other consulting services. CTI focuses on critically and chronically ill patient populations in the specific disease areas of solid organ transplant, hepatitis, infectious disease, hematology/bone marrow transplant and end-stage organ disease including cardiovascular disease, liver disease and kidney disease. With its combined expertise of clinical knowledge and market experience, CTI is uniquely positioned to incorporate both clinical and market driven endpoints and interpretations to provide results.
CTI is headquartered in Cincinnati, Ohio with locations in North America, Europe, and South America. They were recognized by the Cincinnati Business Courier as a “Best Place to Work” in Greater Cincinnati for 2008 and 2009 and were named a “Top Work Place” by the Cincinnati Enquirer in 2010.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.